Ki-67 labeling indices in non-small cell lung cancer: Comparison between image cytometry and flow cytometry

Communications in Clinical Cytometry

Volumn 30, Issue 4, 1997, Pages 186-191

  Ishikuro, Akihiko ^a   Dosaka Akita, Hirotoshi ^a   Kato, Masakazu ^a   Fujino, Michihiro ^a   Isobe, Hiroshi ^a   Miyamoto, Hiroshi ^a   Inoue, Kazuaki ^b   Kawakami, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Flow cytometry; Image cytometry; Ki 67; Non small cell lung cancer; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE S PHASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; NEOPLASM STAGING; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0013330283     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970815)30:4<186::AID-CYTO5>3.0.CO;2-I     Document Type: Article

References (33)

1. Isobe H, Miyamoto H, Shimizu T, Haneda H, Hashimoto M, Inoue K, Mizuno S, Kawakami Y: Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 65:1391-1395, 1990.
2. Miyamoto H, Isobe H, Akita H, Ishikuro A, Endo T, Inoue S, Kawakami Y: The flow cytometric nuclear DNA content, tumor origin, nuclear size and prognosis in squamous cell lung cancer. Int J Oncol 1:325-329, 1992.
3. Shimomatsuya T, Tanigawa N, Muraoka R: Proliferative activity of human tumors: Assessment using hromodeoxyuridine and flow cytometry. Jpn J Cancer Res 82:357-362, 1991.
4. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20, 1983.
5. Dawson AE, Norton JA, Weinberg DS: Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 136:1115-1124, 1990.
6. Yonemura Y, Ooyama S, Sugiyama K, Ninomiya I, Kamata T, Yamaguchi A, Matsumoto H, Miyazaki I: Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer 65:1130-1134, 1990.
7. Schwartz BR, Pinkus G, Bacus S, Toder M, Weinberg DS: Cell proliferation in non-Hodgkin's lymphomas. Am J Pathol 134:327-336. 1989.
8. Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JFR, Blarney RW, Nicholson RI: Ki-67 immunostaining in primary breast cancer: Pathological and clinical associations. Br J Cancer 59:943-947, 1989.
9. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 17:489-503, 1990.
10. Stenfert Kroese MC, Rutgers DH, Wils IS, Van Unnik JAM, Roholl PJM: The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 65:1782-1788, 1990.
11. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991.
12. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991.
13. Takahashi T, Nau MM, Chiba I, Barrer MJ, Rosenberg RK, Vinocour M, Levin M, Pass H, Gazdar AF, Minna JD: p53: A frequent target for genetic abnormalities in lung cancer. Science 246:491-494, 1989.
14. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H, Reissmann PT, Slamon DJ, Holmes EC, Minna JD: Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603-1610, 1990
15. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K: Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 67:589-593, 1992.
16. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon Cardo C: Prognostic implication of p53 nuclear overexpression and high proliferation index of Ki-67 in adult softtissue sarcomas. J Natl Cancer Inst 86:549-554, 1993.
17. Gorczyca W, Markiewski M, Kram A, Tujiak T, Domogara W: Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: Their correlation with Ki-67 growth fraction. VirchowsArch 426:229-233, 1995.
18. Mørkve O, Halvorsen OJ, Stangeland L, Gulsvik A, Laerum OD: Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer 52:851-855, 1992.
19. Fontanini G, Bigini D, Vignati S, Macchiarini P, Pepe S, Angeletti CA, Pingitore R, Squartini F: p53 expression in non small cell lung cancer: Clinical and biological correlations. Anticancer Res 13:737-742, 1993.
20. World Health Organization: Histological Typing of Lung Tumors. 2nd ed Geneva, 1981, pp 25-26.
21. Union Internationale Contre le Cancer. TNM classification of malignant tumors, 3rd Ed. Geneva, Springer-Verlag, 1987, pp 41-45.
22. Bacus S, Flowers JL, Press MF, Bacus JM, McCarthy KS Jr.: The evaluation of estrogen receptor in primary breast carcinoma by computer-associated image analysis. Am J Clin Pathol 90:233-239, 1988.
23. Dosaka-Akila H, Shindoh M, Fujino M, Kinoshita I, Akie K, Katoh M, Kawakami Y: Abnormal p53 expression in human lung cancer associated with histologic subtypes and patient smoking history. Am J Clin Pathol 102:660-664, 1994.
24. Landberg G, Roos G: Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells Cytometry 13:230-240, 1992.
25. Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715, 1984.
26. Aaltomaa S, Lipponen P, Papinoho S, Syrjänen K: Proliferating-cell nuclear antigen (PC10) immunolabeling and other proliferation indices as prognostic factors in breast cancer. J Cancer Res Clin Oncol 119:288-294, 1993.
27. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Kooivula T: Aneuploid DNA content and High S-phase fraction of tumor cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23:277-282, 1987.
28. McGurrin JF, Doria MI Jr, Dawson PJ, Karrison T, Stein HO, Franklin WA: Assessment of tumor cell kinetics by immuno-histochemistry in carcinoma of breast. Cancer 59:1744-1750, 1987.
29. Simony J, Pujol JL, Radal M, Ursule E, Michel FB, Pujol H: In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Res 50:4382-4387, 1990.
30. Fontanini G, Pingitore R, Bigini D, Vignati S, Pepe S, Ruggiero A, Macchiarini P: Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol 141:1285-1290, 1992.
31. Scotlandi K, Serra M, Manara MC, Maurici D, Benini S, Nini G, Campanacci M, Baldini N: Clinical relevance of Ki-67 expression in bone tumors. Cancer 75:806-814, 1995.
32. Willett CG, Warland G, Coen J, Shellito PC, Compton CC: Rectal cancer: The influence of tumor proliferation on response to preoperative irradiation. Int J Oncol Biol Phys 23:57-61, 1995.
33. Harpole DH Jr, Herndon JE 2nd, Wolfe WG, Iglehart JD, Marks JR: A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 55:51-56, 1995.